The International Society of Organoid Research (ISoOR) convened its 2024 annual meeting on From March 7 to 8 i...
Zylox-Tonbridge, a leading medical device company in the peripheral and neurovascular interventional market in China, ha...
US headquartered Cytek Biosciences, Inc. has opened a new 50,000-square-foot facility in Wuxi, China. This strategic mov...
Shenzhen Eureka Biotechnology Co. (EurekaBio), a leading upstream supplier in the cell and gene therapy field, has annou...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Luye Pharma has launched its innovative drug Zepzelca (lurbinectedin) for the treatment of Small Cell Lung Cancer (...
The Hong Kong Polytechnic University (PolyU) Council Chairman Dr LAM Tai-fai and President Prof. Jin-Guan...
China-based MGI Tech has announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S, which ha...
Fujifilm Irvine Technologies, a leader in the innovation and manufacturing of cell culture solutions for the global life...
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...
An international research collaboration has achieved a significant milestone in Alzheimer's disease (AD) diagnosis and m...
Biocytogen Pharmaceuticals (Beijing) Co. has announced an antibody evaluation and option agreement with American bi...
US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...
A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...
Prenetics Global Limited, a leading genomics-driven health sciences company, has announced the signing of a Memorandum o...
Japan's Chugai Pharmaceutical has announced that crovalimab, a humanised complement inhibitor C5 monoclonal antibody, ha...
Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related dis...
I-Mab, a global biotech company exclusively focused on bringing highly differentiated immunotherapies and biologics for ...
